These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34746546)

  • 21. Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.
    Meier R; Piert M; Piontek G; Rudelius M; Oostendorp RA; Senekowitsch-Schmidtke R; Henning TD; Wels WS; Uherek C; Rummeny EJ; Daldrup-Link HE
    Nucl Med Biol; 2008 Jul; 35(5):579-88. PubMed ID: 18589302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.
    Zhu L; Gangadaran P; Kalimuthu S; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S166-S179. PubMed ID: 30092165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.
    Meier R; Golovko D; Tavri S; Henning TD; Knopp C; Piontek G; Rudelius M; Heinrich P; Wels WS; Daldrup-Link H
    Magn Reson Med; 2011 Mar; 65(3):756-63. PubMed ID: 20928869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of therapeutic effects of natural killer (NK) cell-based immunotherapy in mice using in vivo apoptosis bioimaging with a caspase-3 sensor.
    Lee HW; Singh TD; Lee SW; Ha JH; Rehemtulla A; Ahn BC; Jeon YH; Lee J
    FASEB J; 2014 Jul; 28(7):2932-41. PubMed ID: 24736413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.
    Kennis BA; Michel KA; Brugmann WB; Laureano A; Tao RH; Somanchi SS; Einstein SA; Bravo-Alegria JB; Maegawa S; Wahba A; Kiany S; Gordon N; Silla L; Schellingerhout D; Khatua S; Zaky W; Sandberg D; Cooper L; Lee DA; Bankson JA; Gopalakrishnan V
    J Neurooncol; 2019 May; 142(3):395-407. PubMed ID: 30788681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shaping of Natural Killer Cell Antitumor Activity by
    Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
    Front Immunol; 2017; 8():458. PubMed ID: 28491060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
    Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
    Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.
    Swift BE; Williams BA; Kosaka Y; Wang XH; Medin JA; Viswanathan S; Martinez-Lopez J; Keating A
    Haematologica; 2012 Jul; 97(7):1020-8. PubMed ID: 22271890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Golden' exosomes as delivery vehicles to target tumors and overcome intratumoral barriers: in vivo tracking in a model for head and neck cancer.
    Cohen O; Betzer O; Elmaliach-Pnini N; Motiei M; Sadan T; Cohen-Berkman M; Dagan O; Popovtzer A; Yosepovich A; Barhom H; Michaeli S; Popovtzer R
    Biomater Sci; 2021 Mar; 9(6):2103-2114. PubMed ID: 33475633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.
    Yang HG; Kang MC; Kim TY; Hwang I; Jin HT; Sung YC; Eom KS; Kim SW
    J Immunother Cancer; 2019 May; 7(1):138. PubMed ID: 31126350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.
    Felices M; Chu S; Kodal B; Bendzick L; Ryan C; Lenvik AJ; Boylan KLM; Wong HC; Skubitz APN; Miller JS; Geller MA
    Gynecol Oncol; 2017 Jun; 145(3):453-461. PubMed ID: 28236454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
    Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
    Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.
    Geller MA; Knorr DA; Hermanson DA; Pribyl L; Bendzick L; McCullar V; Miller JS; Kaufman DS
    Cytotherapy; 2013 Oct; 15(10):1297-306. PubMed ID: 23993303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purinergic targeting enhances immunotherapy of CD73
    Wang J; Lupo KB; Chambers AM; Matosevic S
    J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive In Vivo Fluorescence Imaging of NK Cells in Preclinical Models of Adoptive Immunotherapy.
    Somanchi SS
    Methods Mol Biol; 2016; 1441():307-16. PubMed ID: 27177677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
    Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
    Front Immunol; 2018; 9():150. PubMed ID: 29456538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration.
    Gangadaran P; Rajendran RL; Ahn BC
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors.
    Lara P; Palma-Florez S; Salas-Huenuleo E; Polakovicova I; Guerrero S; Lobos-Gonzalez L; Campos A; Muñoz L; Jorquera-Cordero C; Varas-Godoy M; Cancino J; Arias E; Villegas J; Cruz LJ; Albericio F; Araya E; Corvalan AH; Quest AFG; Kogan MJ
    J Nanobiotechnology; 2020 Jan; 18(1):20. PubMed ID: 31973696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
    Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
    Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI-guided interventional natural killer cell delivery for liver tumor treatment.
    Su Z; Wang X; Zheng L; Lyu T; Figini M; Wang B; Procissi D; Shangguan J; Sun C; Pan L; Qin L; Zhang B; Velichko Y; Salem R; Yaghmai V; Larson AC; Zhang Z
    Cancer Med; 2018 May; 7(5):1860-1869. PubMed ID: 29601672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.